Skip to main content
logo
Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
12.63
-1.14 (-8.28%)
Sep 1, 2026, 4:00 PM EDT - Market closed

Kazia Therapeutics Cash Flow Statement

Millions AUD. Fiscal year is Jul - Jun.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Net Income
-22.8-20.7-26.78-20.47-25.01-8.42
Depreciation & Amortization
-00.931.871.871.871.27
Asset Writedown & Restructuring Costs
13.3813.38----
Loss (Gain) From Sale of Investments
---0.03---
Stock-Based Compensation
4.820.650.531.161.680.64
Other Operating Activities
-7.18-4.534.82-2.05-2.153
Change in Accounts Receivable
3.543.80.013.45-0.01-5.03
Change in Accounts Payable
-4.57-4.9510.740.57-0.531.01
Change in Other Net Operating Assets
0.03-0.11-0.470.581.77-1.09
Operating Cash Flow
-14.4-13.28-9.58-15.16-22.76-9.11
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Other Investing Activities
-----2.37-
Investing Cash Flow
-----2.37-

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Short-Term Debt Issued
--0.78---
Total Debt Issued
--0.78---
Short-Term Debt Repaid
---0.37---
Total Debt Repaid
---0.37---
Net Debt Issued (Repaid)
--0.41---
Issuance of Common Stock
60.5413.665.9613.374.2229.78
Other Financing Activities
21.032.32-0.38-0.4-0.49-1.67
Financing Cash Flow
81.5615.985.9912.973.7328.11

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Foreign Exchange Rate Adjustments
-0.77-0.020.010.061.18-0.18
Net Cash Flow
66.42.69-3.58-2.12-20.2318.82

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Free Cash Flow
-14.4-13.28-9.58-15.16-22.76-9.11
Free Cash Flow Growth
------
Free Cash Flow Margin
-758.36%-725.97%-386.17%-1515600.00%-227620.00%-60.01%
Free Cash Flow Per Share
-6.45-12.12-18.17-41.12-85.92-38.71
Levered Free Cash Flow
1.1-14.915.05-14.62-16.041.26
Unlevered Free Cash Flow
1.1-14.915.05-14.62-16.041.26

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Change in Working Capital
-2.61-3.01104.330.86-5.59
SEC Filings: 10-K · 10-Q